Literature DB >> 25806253

Alternative to surgery in early stage NSCLC-interventional radiologic approaches.

Kyungmouk Steve Lee1, Bradley B Pua1.   

Abstract

Interventional radiologists have a variety of techniques in their armamentarium to treat pulmonary tumors. While most therapies are targeted to metastasis or palliation, percutaneous thermal ablation represents a potential therapy for not only palliation, but to treat inoperable early stage disease. Although radiofrequency ablation (RFA) is the most studied of these ablative techniques, newer technologies of thermal ablation, such as microwave and cryoablation have emerged as additional options. In this article, we will review the three different thermal ablative modalities, including patient selection, technique, outcomes, complications, and imaging follow-up. A brief discussion of state of the art techniques such as irreversible electroporation (IRE) and catheter directed therapies will also be included.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); catheter directed therapies; cryoablation; interventional radiologic; irreversible electroporation (IRE); microwave ablation; radiofrequency ablation (RFA)

Year:  2013        PMID: 25806253      PMCID: PMC4367721          DOI: 10.3978/j.issn.2218-6751.2013.10.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  111 in total

1.  Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases.

Authors:  Takao Hiraki; Hideo Gobara; Hidefumi Mimura; Yoshifumi Sano; Shinichi Toyooka; Kentaro Shibamoto; Ryotaro Kishi; Mayu Uka; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2010-05-26       Impact factor: 3.464

2.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.

Authors:  Ronald C McGarry; Lech Papiez; Mark Williams; Tia Whitford; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-22       Impact factor: 7.038

3.  The acute effects of transthoracic cryoablation on normal lung evaluated in a porcine model.

Authors:  Yotaro Izumi; Takahiko Oyama; Eiji Ikeda; Masafumi Kawamura; Koichi Kobayashi
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

4.  Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe?

Authors:  Brendan D Skonieczki; Catherine Wells; Elliot J Wasser; Damian E Dupuy
Journal:  Eur J Radiol       Date:  2010-04-30       Impact factor: 3.528

5.  Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms.

Authors:  Takuji Yamagami; Takeharu Kato; Tatsuya Hirota; Rika Yoshimatsu; Tomohiro Matsumoto; Tsunehiko Nishimura
Journal:  J Vasc Interv Radiol       Date:  2006-10       Impact factor: 3.464

6.  Clinical assessment of percutaneous radiofrequency ablation for painful metastatic bone tumors.

Authors:  Hiroyuki Kojima; Noboru Tanigawa; Shuji Kariya; Atsushi Komemushi; Yuzo Shomura; Satoshi Sawada
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Nov-Dec       Impact factor: 2.740

7.  Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors.

Authors:  Yusuke Matsui; Takao Hiraki; Hideo Gobara; Mayu Uka; Yoshihisa Masaoka; Akihiro Tada; Shinichi Toyooka; Toshiharu Mitsuhashi; Hidefumi Mimura; Susumu Kanazawa
Journal:  J Vasc Interv Radiol       Date:  2012-04-17       Impact factor: 3.464

8.  Computed tomographic appearance of lung tumors treated with percutaneous cryoablation.

Authors:  Nobutake Ito; Seishi Nakatsuka; Masanori Inoue; Hideki Yashiro; Sota Oguro; Yotaro Izumi; Masafumi Kawamura; Hiroaki Nomori; Sachio Kuribayashi
Journal:  J Vasc Interv Radiol       Date:  2012-08       Impact factor: 3.464

9.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

10.  Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.

Authors:  Arjun Pennathur; James D Luketich; Ghulam Abbas; Mang Chen; Hiran C Fernando; William E Gooding; Matthew J Schuchert; Sebastien Gilbert; Neil A Christie; Rodney J Landreneau
Journal:  J Thorac Cardiovasc Surg       Date:  2007-08-29       Impact factor: 5.209

View more
  1 in total

1.  Understanding the possibility of image-guided thermal ablation for pulmonary malignancies.

Authors:  Hideki Ujiie; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.